2024 Spring Senior Executive Conference Sunday, May 19 (4pm) - Tuesday, May 21, 2024 (9:30am Europe/London) The Intercontinental London Park Lane One Hamilton Place London United Kingdom

For more information and FAQs, please check out our webpage at http://www.thealda.org/london2024!

When registering, please make sure to click on the "Submit" button to ensure your registration is completed. If you do not receive a confirmation immediately, that means your registration did not go through.

The Spring Senior Executives Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.

Past meetings have focused on proteomics, artificial intelligence, immunology, the transformation of healthcare and trends in pharma. We include a global economic and financial outlook to complement each topical program.

The topic for this Conference is "Trends in Oncology".

For those in London on Saturday, May 18:
ALDA Member-hosted Event (Optional)

Saturday, May 18
5pm-9pm
Member-hosted networking at the London Zoo, hosted by the Zoological Society of London (ZSL) and sponsored by PEAK Scientific and Danaher.
* Join us for a private function for ALDA attendees and their spouse/significant other
* Transportation provided from hotel to zoo and back
* A Networking Reception in the Zoo
* We will have private small group tours of the zoo and animals, behind-the-scenes access!
* There will be short presentations by chief scientists at the ZSL, ending with a networking buffet dinner at the zoo

Sunday, May 19

Reception for Women Executives
Join us for a reception at the Intercontinental Park Lane welcoming women executives to the conference. Enjoy a casual and friendly atmosphere where you can form meaningful connections and discuss top-of-mind issues with peers.

Opening Sunday Evening Dinner Speaker
Zanny Minton Beddoes

A Future View: Global Leadership & Our Global Economy

Zanny Minton Beddoes is the Editor-in-Chief of The Economist, the first woman to hold the position in the history of the publication. Prior to this role, she was The Economist’s business affairs editor, economics editor, and emerging-markets correspondent based in London. She has written surveys of the World Economy, Latin American finance, global finance and Central Asia. Ms. Minton Beddoes has written extensively about international financial issues including enlargement of the European Union, the future of the International Monetary Fund and economic reform in emerging economies. She is a regular television and radio commentator on BBC, MSNBC, PBS, NPR, CNN and CNBC.

Ms. Minton Beddoes will bring this breadth of knowledge and insight to ALDA attendees, sharing the latest developments in the global economy that will impact leaders at our member companies as well as her vision of the future and what it means for ALDA senior executives.

Monday, May 20

Speakers on Oncology

Serena Nik-Zainal, MB, PhD
Professor of Genomic Medicine and Bioinformatics and a National Institute of Health and Care Research (NIHR) Research Professor
University of Cambridge

Genomics in Oncology: The Latest Developments & Potential of Precision Medicine & Early Detection

Dr. Nik-Zainal will share insights from her work and research at Cambridge and the Early Cancer Institute to shed light on the current state of cancer research in genomics, and how these new developments could lead to innovative, attainable, game-changing applications in precision medicine in the near future, and what that means for ALDA member companies.

Litao Zhang, PHD
Global Head of Discovery Technologies & Molecular Pharmacology
Therapeutics Discovery
Johnson & Johnson Innovative Medicine

Next Gen Technology Innovation to Accelerate Oncology Drug Discovery

Dr. Zhang will share her work and perspectives on the future of drug discovery, innovative therapies, her organization’s commitment to transforming drug discovery for cancer care, and what it means for ALDA members. This session will provide a unique opportunity to delve into the next wave technology innovation for the future of Oncology and understand how drug discovery innovation is shaping patient outcomes.

Darren Treanor MD, PhD
Director, National Pathology Imaging Co-operative
Consultant Pathologist in Liver and Gastrointestinal Pathology, Leeds Teaching Hospitals NHS Trust and Honorary Clinical Professor of Pathology, University of Leeds

Digital Pathology: Advancements and Applications in Modern Oncology

Dr. Darren Treanor is a Consultant Pathologist at Leeds Teaching Hospitals NHS Trust and a Senior Clinical Lecturer at the University of Leeds. He is known for his work in digital pathology, focusing on the development and implementation of digital pathology systems to improve diagnostic efficiency and educational resources within the medical field.

He is also Guest Professor in Digital Pathology at Linköping University, Sweden, where he works with the university and hospital teams on digital pathology research in a well-established project where 100% of clinical slides are scanned. In his session, Dr. Treanor will share the latest developments in digital pathology as it relates to oncology, including work on a national digital pathology system for diagnosis using AI.

Executive Panel: Transforming Oncology through Liquid Biopsy Innovations

Helmy Eltoukhy, PhD, Chairman and co-Chief Executive Officer, Guardant Health
Mike Nolan, Chief Executive Officer, Freenome
Valerie Dixon, Managing Director, Healthcare Investment Banking Group, Morgan Stanley (Moderator)

In this enlightening panel session, attendees will have the unique opportunity to hear from senior executives of premier liquid biopsy companies. Liquid biopsy is transforming oncology by enabling earlier detection, personalized treatment strategies, and real-time monitoring of disease progression and response to treatment.

The session will explore the significant impact of liquid biopsy on current oncology trends and discuss its broader implications for executives in attendance, highlighting how these innovations are reshaping cancer care and research.

More panelists will be announced shortly.

Tuesday, May 21

Breakfast for Women Executives
An educational and informative breakfast for women executives in attendance, as the CEO of the London Stock Exchange, Julia Hoggett, will sit down for an informal moderated Q&A and take questions from the audience about navigating her career, managing her current position, and other lessons in leadership.

Julia Hoggett
CEO
London Stock Exchange

The State of Capital Markets

Tuesday's programming will kick off with a presentation by the CEO of the London Stock Exchange, Julia Hoggett, who will share the latest on the state of capital markets around the world, the economy in the UK, and the case for UK markets.

Closing Keynote
Siddhartha Mukherjee

Siddhartha Mukherjee, a renowned oncologist, biologist, and Pulitzer Prize-winning author, will serve as our distinguished closing speaker. Dr. Mukherjee's groundbreaking work in cancer research and his profound insights into the cellular basis of cancer have positioned him as a pivotal figure in the field. His best-selling books, "The Emperor of All Maladies: A Biography of Cancer," artfully blends scientific exploration with historical narrative, offering a deep and engaging perspective on the disease. Additionally, his more recent work, "The Gene: An Intimate History," delves into the human genome, providing crucial insights that are highly relevant for cutting-edge cancer research and treatment.

Dr. Mukherjee will delve into the latest advancements in oncology, providing attendees with an opportunity to gain insights from one of the leading experts in the field. His focus on innovation in cancer treatment and diagnosis is sure to inform attendees on current trends and future directions in cancer research, while inspiring ideas for a collaborative approach to tackling these challenges in this rapidly evolving sector. Don't miss this chance to learn from and interact with one of the luminaries in cancer research and treatment.

Who Should Attend:

Our semi-annual conferences are designed for member company C-suite executives, presidents and their senior executive teams.

Registration Fees: These fees are available through 05/17/2024
Name	Price	Available To
Early Bird First Registrant (Until October 31)	$2,695.00	Member
Early Bird Additional Registrants (Until October 31)	$2,195.00	Member
First Registrant (after October 31)	$2,795.00	Member
Additional Registrants (After October 31)	$2,295.00	Member

Cancellation and Other Policies:

Cancellation:
**No refunds of Conference registration fees will be made for registration cancellations after Friday, May 10, however, if you must cancel, please remember that you are also responsible for canceling your hotel reservations.

For more information please contact:

Carol Starke
Manager, Meetings & Administration
Analytical, Life Science & Diagnostics Association (ALDA)
Phone: (703) 647-6361
Email: CStarke@thealda.org